24 results
F-3
SCNI
Scinai Immunotherapeutics Ltd
30 Jan 24
Shelf registration (foreign)
4:19pm
or “excess distribution” cannot be offset by any losses for such years. Additionally, any gains realized on the sale of the Securities cannot
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
8:24am
liability for amounts allocated to years before the year of disposition or “excess distribution” cannot be offset by any losses for such years
F-1/A
SCNI
Scinai Immunotherapeutics Ltd
22 Dec 23
Registration statement (foreign) (amended)
9:11am
to each other year.
The tax liability for amounts allocated to years before the year of disposition or “excess distribution” cannot be offset by any
F-1
SCNI
Scinai Immunotherapeutics Ltd
30 Oct 23
Registration statement (foreign)
4:59pm
for amounts allocated to years before the year of disposition or “excess distribution” cannot be offset by any losses for such years. Additionally
424B5
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Prospectus supplement for primary offering
10:03am
distribution” cannot be offset by any losses for such years. Additionally, any gains realized on the sale of the Securities cannot be treated
F-3
iqo699o4qhnzcg c0cg
18 Aug 23
Shelf registration (foreign)
4:16pm
10-Q
ax551cvhbshl
15 May 23
Quarterly report
4:49pm
10-K
9s0d3 kkje4f8
17 Apr 23
Annual report
4:06pm
6-K/A
EX-99.1
0qmy otszpd59nbts7x
29 Aug 22
BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update
4:51pm
6-K
EX-99.1
72vwu
25 Aug 22
BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update
4:02pm
6-K
EX-99.1
2h6zyov0g7 nwooc0v
2 Dec 21
BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
4:15pm
6-K
EX-99.1
o2i8lm
13 May 21
BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results
5:17pm
6-K
EX-99.3
ovwj jgipe53y4
28 Jan 21
BiondVax Announces Third Quarter 2020 Financial Results & Business Update
5:25pm
6-K
EX-99.1
ix2b56v1
28 Jan 21
BiondVax Announces Third Quarter 2020 Financial Results & Business Update
5:25pm
6-K
EX-99.2
5vvrne
2 Oct 20
Condensed Interim Financial Statements
12:00am
F-1/A
p2ejq
7 Jun 19
Registration statement (foreign) (amended)
11:42am
F-1/A
e80yb6cuikwhq6f
6 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1/A
7jktb
30 May 19
Registration statement (foreign) (amended)
8:46am